MEDEX AS - 10080187 | ScoreStorybook | Print Summary Report

keywords

  • eriarstiabi osutamine

Employees and salaries

MEDEX AS

Number of employees and estimated average salaries
?

MEDEX AS

Employee taxes and performance analysis
?
QuarterLabor taxes
paid
Number of employees
Turnover
Per Employee
Profit
per employee
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................
2015 I........................

Deciders and beneficiaries

MEDEX AS

Decision-makers
?

Former decision-makers

Liis Pruusapuu
★★★★

......

Credit Score: Trustworthy

Reputation score: 3770

Date of birth: ......

Active relations 7


*

MEDEX AS

Former decision-makers
?
Toomas Tein
★★★★

......

Credit Score: Trustworthy

Reputation score: 330

Date of birth: ......

Active relations 1

Toomas Tein
★★★★

......

Credit Score: Trustworthy

Reputation score: 330

Date of birth: ......

Active relations 1

Aalo Eller
★★★★

......

Credit Score: None

Reputation score: None

Date of birth: ......

Active relations 0

Toomas Tein
★★★★

......

Credit Score: Trustworthy

Reputation score: 330

Date of birth: ......

Active relations 1

MEDEX AS

History of right of representation
?
Health Care
28y
Estonia
 
Liis Pruusapuu ... - ...
Toomas Tein ... - ...
Aalo Eller ... - ...
Toomas Tein ... - ...
Toomas Tein ... - ...
1996
2000
2004
2008
2013
2017
2021
2025
1996
1999
2001
2004
2007
2009
2012
2014
2017
2020
2022
2025

MEDEX AS

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.51
..................
0.34
..................
0.01
..................
0.01
..................
0.01
..................

MEDEX AS

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
0.38
............
0.01
............
0.19
............
!
............
0.01
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnding
0.01
..................
0.01
..................
!
..................
!
..................
0.01
..................
!
..................
0.34
..................
0.51
..................
0.50
..................

MEDEX AS

Subsidiaries and associates
?

Former subsidiaries and associates

Former subsidiaries and associates

NameCredit ScorePaymentBeginningEnding
!
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

MEDEX AS

Goodwill

MEDEX AS

Taxes paid and estimated average salaries

MEDEX AS

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................
2015 IV* ............* ..............................
2015 III* ............* ..............................
2015 II* ............* ..............................
2015 I* ............* ..............................

MEDEX AS

Sales revenue by business area

MEDEX AS

Sales revenue by country

MEDEX AS

Financial indicators and prognosis

MEDEX AS

Financial raiting: "VERY GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

MEDEX AS

Real estate as of 07.02.2025

Active and unactive real estate

igon F......
igon K......

MEDEX AS

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 11.07.2024 ......
2022 01.01.2022–31.12.2022 01.08.2023 ......
2021 01.01.2021–31.12.2021 30.06.2022 ......
2020 01.01.2020–31.12.2020 14.05.2021 ......
2019 01.01.2019–31.12.2019 21.05.2020 ......
2018 01.01.2018–31.12.2018 19.06.2019 ......
2017 01.01.2017–31.12.2017 15.05.2018 ......
2016 01.01.2016–31.12.2016 24.05.2017 ......
2015 01.01.2015–31.12.2015 30.05.2016 ......
2014 01.01.2014–31.12.2014 25.06.2015 ......
2013 01.01.2013–31.12.2013 16.05.2014 ......
2012 01.01.2012–31.12.2012 30.04.2013 ......
2011 01.01.2011–31.12.2011 14.06.2012 ......
2010 01.01.2010–31.12.2010 16.06.2011 ......
2009 01.01.2009–31.12.2009 02.06.2010 ......
2008 01.01.2008–31.12.2008 16.06.2009 ......
2007 01.01.2007–31.12.2007 30.06.2008 ......
2006 01.01.2006–31.12.2006 15.06.2007 ......
2005 01.01.2005–31.12.2005 19.06.2006 ......
2004 01.01.2004–31.12.2004 01.07.2005 ......
2003 01.01.2003–31.12.2003 16.06.2004 ......
2002 01.01.2002–31.12.2002 16.06.2003 ......
2001 01.01.2001–31.12.2001 01.07.2002 ......
2000 01.01.2000–31.12.2000 02.07.2001 ......

Liabilities and debts

MEDEX AS

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

MEDEX AS

Reports and assets-liabilities overview 07.02.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......

Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

MEDEX AS

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Private debt ...... €

Total debt claims: ...... €

Latest events
...... ......

MEDEX AS

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......
2015 IV* ...... €...... €...... €...... €......
2015 III* ...... €...... €...... €...... €......
2015 II* ...... €...... €...... €...... €......
2015 I* ...... €...... €...... €...... €......

MEDEX AS

Bailiff's enforcement proceedings as of 07.02.2025
?

Bailiff's enforcement proceedings MISSING

MEDEX AS

Regulations of the Payment Order Department as of 07.02.2025
?

Regulations of the Payment Order Department MISSING

MEDEX AS

Court orders in the register as of 07.02.2025
?
Logo

Trahvihoiatusmäärus: majandusaasta aruanne esitamata

08.07.2024

Regulation number: Ä 20001278 / M9

Regulation status has entered into force: 13.07.2024

Date of enforcement of order or additional period: 08.07.2024

Regulation status: Puudused kõrvaldatud


Logo

Lõivu tasumise nõudmise määrus (NAP)

01.07.2024

Regulation number: Ä 20001278 / M8

Regulation status has entered into force: 02.07.2024

Date of enforcement of order or additional period: 07.07.2024

Regulation status: Puudused kõrvaldatud


Logo

Kandemäärus ex officio

31.05.2024

Regulation number: Ä 20001278 / 18

Regulation status has entered into force: 31.05.2024

Regulation status: Allkirjastatud


Logo

Korraldav määrus

16.05.2024

Regulation number: Ä 20001278 / M7

Regulation status has entered into force: 16.05.2024

Date of enforcement of order or additional period: 16.05.2024

Regulation status: Jõustunud


Logo

Eitav kandemäärus: puudused kõrvaldamata

25.03.2024

Regulation number: Ä 20001278 / 17

Regulation status has entered into force: 25.03.2024

Regulation status: Allkirjastatud


Logo

Puuduste kõrvaldamise määrus

01.03.2024

Regulation number: Ä 20001278 / M6

Regulation status has entered into force: 01.03.2024

Regulation status: Allkirjastatud


Logo

Korraldav määrus

12.02.2024

Regulation number: Ä 20001278 / M5

Regulation status has entered into force: 12.02.2024

Date of enforcement of order or additional period: 12.02.2024

Regulation status: Jõustunud


Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

28.04.2022

Regulation number: Ä 20001278 / M4

Regulation status has entered into force: 02.05.2022

Date of enforcement of order or additional period: 28.04.2022

Regulation status: Puudused kõrvaldatud


Logo

Puuduste kõrvaldamise määrus

11.03.2022

Regulation number: Ä 20001278 / M3

Regulation status has entered into force: 13.03.2022

Date of enforcement of order or additional period: 11.03.2022

Regulation status: Puudused kõrvaldatud


MEDEX AS

Decisions of the Consumer Disputes Committee as of 07.02.2025
?

Consumer disputes MISSING

MEDEX AS

Court hearings as of 07.02.2025
?

Court hearings MISSING

MEDEX AS

Rulings as of 07.02.2025
?

Court settlemets MISSING

MEDEX AS

Notices and announcements as of 07.02.2025
?

Announcements MISSING

Marketing

Business network

MEDEX AS

Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

MEDEX AS

Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.